Bassler Bonnie L 4

What Happened

• Bonnie L. Bassler, a director of Royalty Pharma plc (RPRX), was issued 689 Class A Ordinary Shares on 2026-06-30. The filing reports an acquisition valued at $54.40 per share, totaling $37,481. This was an award/grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-06-30 — 689 shares at $54.40 each (total $37,481).
• Shares issued under: the Issuer's 2020 Independent Director Equity Incentive Plan.
• Footnote: The shares were issued in lieu of a quarterly director retainer payment of $37,500 (per filing footnote).
• Shares owned after transaction: not specified in the provided filing summary.
• Filing timeliness: Form filed on 2026-06-30 (same date as transaction); no late filing indicated.

Context

• This was an equity award issued in lieu of cash retainer for director compensation — a routine corporate governance action common for non-employee directors. Such awards are compensation, not a direct vote of confidence like an open-market purchase; they do not necessarily signal insider sentiment about the stock.